6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
10m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
42m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
43m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
43m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
43m ago	First Quantum Minerals Reports First Quarter 2026 Results

About

Oncolytics Biotech Inc (TO:ONC) — investor relations, events, news, and company updates on 6ix.

Latest News

Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer

Oncolytics Biotech® Completes Domicile Change to the United States

Oncolytics Biotech® to Present New Mechanistic and Translational Data Supporting Pelareorep as an Immune-Priming Backbone at AACR 2026

Oncolytics Biotech® Launches Randomized Colorectal Cancer Study

Oncolytics Biotech® to Prioritize Registration-Focused Programs in Anal and Colorectal Cancer

Financials

Revenue

CA$0

Market Cap

CA$142.51 M

EPS

-0.37

Community Chat

Ask AI